What are the New Developments in Urinary, Serum and Tissue Biomarkers in Prostate Cancer?

Journal Title: Üroonkoloji Bülteni - Year 2017, Vol 16, Issue 3

Abstract

Currently the accepted screening tools for prostate cancer are prostate specific antigen (PSA) and rectal examination. PSA is specific to prostate, but not to prostate cancer. Therefore, identifying prostate cancer only by serum PSA measurement has low specificity and may lead to false positive results and unnecessary biopsies. Due to these problems, it is investigated to increase the effectiveness of PSA and/or to find new biomarkers. However, it does not seem possible to have the adequate benefit from only one biomarker due to heterogeneous feature of prostate cancer. Therefore, in the recent years, combined use of biomarkers became a current issue and higher sensitivity and specificity rates were established.

Authors and Affiliations

Hayrettin Şahin, Mehmet Çetinkaya, Hasan Deliktaş

Keywords

Related Articles

Comparison of Subcapsular and Total Orchiectomy in Patients with Prostate Cancer

Objective: We aimed to compare the oncologic and functional outcomes of patients who underwent subcapsular or total orchiectomy for surgical castration in prostate cancer. Materials and Methods: We studied 65 patients w...

Risk Factors for Adrenal Invasion in Renal Cell Carcinoma

Objective: In this study, we aimed to describe the risk factors associated with adrenal invasion in patients who were diagnosed with renal cell carcinoma (RCC) after radical nephrectomy and identify which risk factors ar...

Importance of the Re-Transurethral Resection in Bladder Cancer Treatment

Objective: In this study, we aimed to investigate the importance of repeat-transurethral resection (re-TUR) in bladder cancer treatment. Materials and Methods: A total of 90 with the diagnosis of grade pTa and all pT1 bl...

Do Length and Tumor Grades of Positive Surgical Margin Have an Impact on Biochemical Recurrence After Prostatectomy?

Objective: Biochemical recurrence (BCR) does not occur in all patients with surgical margin (SM) positivity after radical prostatectomy (RP). The aim of our study is to evaluate the effect of additional features such as...

A Rare Presentation of Germ Cell Neoplasia: Persistant Müllerian Duct Syndrome

Persistent Müllerian duct syndrome is a rare form of pseudohermaphroditism. This article is made of two case reports showing malignant transformation. The first case was a 36-year-old male who presented with infertility....

Download PDF file
  • EP ID EP226678
  • DOI 10.4274/uob.620
  • Views 134
  • Downloads 0

How To Cite

Hayrettin Şahin, Mehmet Çetinkaya, Hasan Deliktaş (2017). What are the New Developments in Urinary, Serum and Tissue Biomarkers in Prostate Cancer?. Üroonkoloji Bülteni, 16(3), 95-100. https://europub.co.uk/articles/-A-226678